Long duration of complete remissions in acute leukemia.
Jean François Bernard
Abstract
Jean François Bernard
Abstract
Reports are presented of 13 cases of acute leukemia in which the patient has survived for more than 4 years. In 12 of these cases, remission was complete for more than 3 years. Seven patients continue in remission and in good general health variously 8 years 6 months, 6 years 7 months (2 patients), 4 years 9 months (2 patients), 4 years 8 months, and 4 years 3 months after the onset of acute leukemia. The variety of forms observed, the relatively high proportion of myeloblastic leukemias, and the diversity and occasional mildness of the therapy applied are evidence in this series in favor of the intervention of the defense mechanisms of the individual patient. The existence of such long-term remissions obtained with proved therapy should be taken into consideration in evaluating the effects of new treatments. Hopes of long-term stabilization of acute leukemias no longer appear completely unreasonable. The aim of all therapy of acute leukemia is to increase the number of patients in long-term remission.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Reports are presented of 13 cases of acute leukemia in which the patient has survived for more than 4 years. In 12 of these cases, remission was complete for more than 3 years. Seven patients continue in remission and in good general health variously 8 years 6 months, 6 years 7 months (2 patients), 4 years 9 months (2 patients), 4 years 8 months, and 4 years 3 months after the onset of acute leukemia. The variety of forms observed, the relatively high proportion of myeloblastic leukemias, and the diversity and occasional mildness of the therapy applied are evidence in this series in favor of the intervention of the defense mechanisms of the individual patient. The existence of such long-term remissions obtained with proved therapy should be taken into consideration in evaluating the effects of new treatments. Hopes of long-term stabilization of acute leukemias no longer appear completely unreasonable. The aim of all therapy of acute leukemia is to increase the number of patients in long-term remission.
Key concepts: Medicine, Complete remission, Acute leukemia, Acute myeloblastic leukemia, Leukemia, Pediatrics, Surgery, Internal medicine